Navigation Links
National Eye Institute Launches Ancillary Study to AREDS2 With ForeseeHome(TM) AMD Monitor
Date:6/15/2010

ST. LOUIS, June 15 /PRNewswire/ -- The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2).  AREDS2 is a nationwide study of 4,000 individuals at moderate to high risk for developing age-related macular degeneration (AMD) to determine whether oral supplementation of lutein/zeaxanthin and omega-3 fatty acids can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.

The objective of this ancillary study is to determine if home monitoring using the ForeseeHome™ AMD Monitor would lead to earlier detection of wet AMD when compared with standard care, and result in better visual acuity following therapy at one year.

The ForeseeHome™ AMD Monitor is the first ophthalmic device designed to provide ongoing monitoring of patients with AMD between visits to their eye care professional.  Patients complete a brief exam on their ForeseeHome™ AMD Monitor in the comfort of their own home, and data are transmitted to the Notal Vision Data Monitoring Center.  The award winning ergonomic design of the ForeseeHome™ AMD Monitor is comfortable and easy to use for patients at risk of vision loss from AMD.

Notal Vision was founded by a team of medical professionals determined to develop better methods of AMD monitoring and reduce vision loss associated with AMD. For more information, please visit www.notalvision.com.

The National Eye Institute (NEI) is part of the National Institutes of Health (NIH) and is the Federal government's lead agency for vision research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. For more information, visit the NEI Website at http://www.nei.nih.gov/.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.


'/>"/>
SOURCE Notal Vision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
2. Veteran International Health Care Executive Appointed CEO of BeneChill(R)
3. Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound
4. AstraZeneca to Support Drug-Induced Liver Injury Network at the National Institutes of Health
5. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
6. HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy
7. National Anesthesia Services, Inc. Celebrates 21 Years of Dynamic Growth and Achievement
8. Systech International and Videojet Brazil Partner to Meet Brazils Emerging Pharmaceutical Regulatory Requirements
9. Drug Production in Afghanistan: A Challenge for the International Community
10. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
11. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... , Jan 23, 2017 Research and Markets ... Analysis & Trends - Product - Forecast to 2025" report to ... Report Highlights: ... and future market trends to identify the investment opportunities ... Key market trends across the business segments, Regions and ...
(Date:1/23/2017)... -- Stock-Callers.com today presents the following Generic Drugs ... ), Sophiris Bio Inc. (NASDAQ: SPHS ), Momenta ... Inc. (NASDAQ: AGRX ). These companies are part ... trade on Friday, January 20 th , 2017, with the ... health care companies in the S&P 500 also were sinking ...
(Date:1/23/2017)... , 23. Januar 2017  ResMed (NYSE: ... ) und 3B Medical ( Winter Haven, Florida ... eine Vereinbarung über die Beilegung aller globalen Rechtsstreitigkeiten zwischen ... der Verkauf ihrer bestehenden Produkte im Tausch gegen ... Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology:
(Date:1/23/2017)... , ... January 23, 2017 , ... ... educational institution’s inaugural K-20 Education Summit to be held March 23-25, 2017 in ... by Jan. 25, 2017. , The keynote speakers include Dr. Michelle R. Weise, ...
(Date:1/23/2017)... Dc (PRWEB) , ... January 23, 2017 , ... ... American University is taught by healthcare management and evaluation leaders with decades of ... fee-for-service to pay-for-value in the United States healthcare system, there is a renewed ...
(Date:1/23/2017)... ... January 23, 2017 , ... METTLER TOLEDO has ... Chemistry by Applying Simple PAT Tools . , Crystallization is a ... the desired product. Chemists now spend more time developing better intermediate and ...
(Date:1/23/2017)... ... ... Old School Labs™, makers of the wildly popular all-natural sports supplements based ... its growing team of brand ambassadors. The Olympia top finisher and former Big 12 ... year was able to turn professional, participating in the 2013 NPC USA Championships in ...
(Date:1/23/2017)... ... 2017 , ... “Crossing the Bar”: a moving and eloquent drama depicting ... the Bar” is the creation of published author, Charlotte Hotte, a North Carolina native, ... the inspiration of the book to her sister, Denise, wishes to acknowledge her savior, ...
Breaking Medicine News(10 mins):